Literature DB >> 24634197

Radiocopper for the imaging of copper metabolism.

Rebekka Hueting1.   

Abstract

The redox-active transition metal copper is an essential trace element for growth and development and serves as a structural or catalytic cofactor for many enzymes in a range of physiological processes. Mammalian copper homeostasis is tightly regulated, and an imbalance in copper metabolism is implicated in various pathological disorders. Radioactive copper isotopes, in particular (64) Cu (t1/2  = 12.7 h) and (67) Cu (t1/2  = 62.01 h), have made important contributions to the understanding of copper metabolism in health and disease. This review gives a brief account of how radiolabelled copper(II) salts and bioreductive copper complexes have been used to trace copper uptake, transport and efflux in vitro and in vivo. Recently, positron emission tomography (PET) has emerged as a noninvasive tool to image copper metabolism in living subjects and (64) Cu-PET is investigated for the study of copper-related neurological disorders, genetic diseases and cancer.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; Wilson's disease; copper metabolism; radiocopper; tumour imaging

Mesh:

Substances:

Year:  2014        PMID: 24634197     DOI: 10.1002/jlcr.3155

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  10 in total

1.  Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of 64Cu acetate and 64CuGTSM.

Authors:  Erica M Andreozzi; Julia Baguña Torres; Kavitha Sunassee; Joel Dunn; Simon Walker-Samuel; Istvan Szanda; Philip J Blower
Journal:  Metallomics       Date:  2017-11-15       Impact factor: 4.526

Review 2.  Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Authors:  George Crișan; Nastasia Sanda Moldovean-Cioroianu; Diana-Gabriela Timaru; Gabriel Andrieș; Călin Căinap; Vasile Chiș
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 3.  Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.

Authors:  Fang Xie; Fangyu Peng
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  A nuclear chocolate box: the periodic table of nuclear medicine.

Authors:  Philip J Blower
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

Review 5.  Copper-64: a real theranostic agent.

Authors:  Bianca Gutfilen; Sergio Al Souza; Gianluca Valentini
Journal:  Drug Des Devel Ther       Date:  2018-10-02       Impact factor: 4.162

Review 6.  Insights into Trace Metal Metabolism in Health and Disease from PET: "PET Metallomics".

Authors:  Joanna J Bartnicka; Philip J Blower
Journal:  J Nucl Med       Date:  2018-07-05       Impact factor: 10.057

7.  Opportunities and challenges for metal chemistry in molecular imaging: from gamma camera imaging to PET and multimodality imaging.

Authors:  Richard Southworth; Rafael Torres Martin de Rosales; Levente K Meszaros; Michelle T Ma; Gregory E D Mullen; Gilbert Fruhwirth; Jennifer D Young; Cinzia Imberti; Julia Bagunya-Torres; Erica Andreozzi; Philip J Blower
Journal:  Adv Inorg Chem       Date:  2015-11-16       Impact factor: 3.282

8.  A new technique for the radiolabelling of mixed leukocytes with zirconium-89 for inflammation imaging with positron emission tomography.

Authors:  M Fairclough; C Prenant; B Ellis; H Boutin; A McMahon; G Brown; P Locatelli; A K P Jones
Journal:  J Labelled Comp Radiopharm       Date:  2016-04-08       Impact factor: 1.921

9.  Pilot Study of 64Cu(I) for PET Imaging of Melanoma.

Authors:  Lei Jiang; Yingfeng Tu; Xiang Hu; Ande Bao; Hao Chen; Xiaowei Ma; Tim Doyle; Hongcheng Shi; Zhen Cheng
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

10.  Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics.

Authors:  Marina Lledos; Vincenzo Mirabello; Sophia Sarpaki; Haobo Ge; Hubert J Smugowski; Laurence Carroll; Eric O Aboagye; Franklin I Aigbirhio; Stanley W Botchway; Jonathan R Dilworth; David G Calatayud; Pawel K Plucinski; Gareth J Price; Sofia I Pascu
Journal:  ChemNanoMat       Date:  2018-02-08       Impact factor: 3.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.